The practice group at Clifford Chance is well positioned to assist major pharma and biotech players with IP, regulatory matters and corporate transactions in the life science sphere. The team has particular expertise in patent litigation and preliminary injunction applications. Leadership of the department is split between Miquel Montañá, Josep Montefusco, Guillermo Guardia and Carme Briera. Montañá specialises in dispute resolution, IP and competition law; Montefusco handles IP litigation, competition law and advertising mandates; Guardia majors on M&A, private equity and joint ventures. Briera, for her part, assists with public law matters in the telecoms and healthcare spaces. Also noted is litigation specialist Adrián Crespo.

Based in Barcelona, Faus Moliner is highly specialised in assisting pharma and medical device companies with regulatory, transactional and contentious issues in the space, namely litigation, the drafting of commercial agreements, public procurement and competition litigation mandates. Leadership is shared between Jordi Faus, who specialises in pharma-sector policy mandates and commercial transactions, and Xavier Moliner, who majors on administrative, civil and commercial litigation. Eduard Rodellar is another key practitioner who regularly works on clinical trials and observational studies involving medicinal products and medical devices.  Also noted are Lluís Alcover, who assists with market access and price and reimbursement matters; and Juan Martínez, who covers administrative and product liability litigation.

The department at Uría Menéndez is a strong choice for regulatory matters, commercial transactions and IP work in the life science sphere. Core areas of expertise include pricing and market access strategies, regulatory compliance and the commercialisation of new drugs. Leadership is shared between Beatriz Cocina, Montiano Monteagudo, Ingrid Pi and Francisco Javier García. Cocina’s broad practice takes in contractual, commercial, administrative and regulatory mandates; Monteagudo handles IP, competition and corporate law matters; Pi focuses on IP and competition litigation; and García, for his part, specialises in IP litigation and data privacy matters.

The practice at Baker McKenzie is well placed to handle regulatory, product registration, public procurement, healthcare compliance, IP and commercial matters as they pertain to the life science space. Following the July 2025 departure of Montserrat Llopart, leadership is shared between Madrid-based Cecilia Pastor and Barcelona-based Elisabet Cots. Pastor is highly specialised in M&A in the pharma space, as well as contractual matters and corporate restructurings. Cots, for her part, draws on notable experience in product regulation, environmental and regulatory life sciences mandates. Ester Navas is an additional key contact for regulatory, compliance, advertising, price discounting and contracting matters in the healthcare sector.

The practice at Bird & Bird is equipped to assist pharma, biotech and medical device companies with contentious, regulatory, corporate and IP-related issues. Leadership of the group is shared between Coral Yáñez, Manuel Lobato, José Miguel Lissén, Lourdes Ayala and Miguel Pastur. Yáñez acts as national managing partner and advises on regulatory issues concerning clinical trials, marketing authorisations and price fixing; Lobato assists with patent and trade secrets litigation, as well as trade mark and copyright law; Lissén focuses on patents, trade secrets and competition law; Ayala covers corporate and M&A matters; and Pastur advises on employment law matters in the healthcare sphere.

Cuatrecasas‘s life sciences and healthcare practice regularly assists research institutes and biotech, medical device and cosmetic companies with contentious and non-contentious corporate, competition and regulatory mandates. Elena Cuatrecasas heads up the department and specialises in financing and M&A transactions in the pharma, biotech, healthcare and TMT sectors. Also noted are Jorge Robles, who handles regulatory, contentious and public law matters in the space; and Ariadna Casanueva, who has focused her practice on healthcare compliance and M&A transactions.

Eversheds Sutherland‘s practice group is frequently instructed by pharma and medical device companies seeking assistance with patent litigation, licensing and contractual matters, product liability mandates and market access issues. Leadership of the team is shared between Marta González, who specialises in representing clients in the life science space in litigation relating to patents, defective medications and unfair competition; Kiko Carrión, who has focused his practice on patent and product liability matters concerning pharma products and medical devices; and Alberto Dorrego, who excels in public and administrative law. Eduardo Buitrón primarily deals with pre-litigation and dispute resolution mandates.

The team at Fieldfisher is well placed to handle regulatory, compliance, data protection, market access, clinical trials, advertising, pricing, unfair competition and public procurement mandates on behalf of major multinational pharma companies. Héctor Jausàs steers the practice and specialises in advising life sciences clients on regulatory and market access matters, advertising, as well as commercial hiring and compliance. Also noted is Gemma Colomer, who has focused her practice on regulatory matters and contentious proceedings.

The team at Garrigues is equipped to advise domestic and multinational pharma and biotech companies on commercial, regulatory, contractual, IP and competition law matters. Leadership of the department is entrusted to José Fernández-Rañada, whose broad practice takes in regulatory matters and company sale and purchase transactions, spin-offs and corporate restructuring processes in the life sciences space. Also noted are Carolina Pina, an IP specialist; Juan Manuel Cabeza, who focuses on administrative law; and Javier Manchado, who handles administrative law and public procurement work.

The life sciences and healthcare group at Hogan Lovells Spain is frequently instructed by international pharma, medical device and biotech companies seeking assistance with a range of regulatory, transactional, IP and product liability matters. Leadership of the team is shared between Ana Castedo, who specialises in IP litigation and unfair competition matters, and Alex Dolmans, who also directs the firm’s corporate and M&A department and draws on extensive experience advising on transactional mandates in the life sciences space. Other key practitioners include Inmaculada Lorenzo, a name to note for IP litigation; Margarita Morales, who focuses on commercial litigation; and Álvaro Abad, who regularly assists with market access, regulatory, promotion, compliance and marketing issues in the life sciences space.

The life sciences group at Pérez-Llorca is well-versed in assisting laboratories, pharma companies and medical device manufacturers with procurement, competition law, IP and transactional matters in the life sciences space. Leadership of the team is shared between Eduardo Castillo, who specialises in patent litigation, and Juan Rodríguez Cárcamo, who focuses on public law and regulatory matters. Also noted is administrative law specialist Natalia Olmos, who frequently assists with asset liability claims. Rais Amils left the firm in December 2024.

The life sciences group at DLA Piper is well positioned to provide pharma, medical device and tech health companies with support on M&A transactions, financings, competition, regulatory and contentious mandates. Paula González de Castejón steers the practice and specialises in IP work in the life sciences space, in addition to advising pharmaceutical and medical device companies on regulatory and advertising issues. Also noted is Elisa Lorenzo, who assists with regulatory matters, clinical trial agreements, and compliance issues.

DWF-RCD is routinely instructed by public research institutes, biotech foundations and pharma companies seeking assistance with regulatory, competition, IP, transactional and data protection matters. Barcelona-based Ignasi Costas steers the practice and specialises in corporate, commercial and private equity matters. Other key practitioners include Oscar Alegre, a name to note for life sciences, IP, M&A work; Judith Saladrigas, a contact for start-ups, knowledge-based institutions, universities, research centres and private investors; and Alejandro Griffiths, who assists with corporate matters, intellectual and industrial property protection and technology transfers.

The life sciences practice group at Gómez-Acebo & Pombo is frequently instructed by biotech, pharmaceutical and medical device companies seeking assistance with transactional, IP, competition law, and pricing and distribution matters. Irene Fernández Puyol heads up the team and specialises in regulatory mandates involving medicinal products, medical devices and healthcare services requirements and obligations. Also noted are Jesús Muñoz Delgado, who focuses on IP, and Barcelona-based Iñigo Igartua, who handles sector-related regulatory, marketing and antitrust matters. Rais Amils, who excels in matters involving pharma patents, joined from Pérez-Llorca in December 2024.

The team at Andersen in Spain regularly supports listed companies, public institutions and multinational groups in the pharma and life sciences sectors in corporate, compliance, competition, regulatory and IP mandates. Leadership is entrusted to Barcelona-based Juan Ignacio Alonso Dregi, who specialises in corporate law, M&A and restructuring. Also noted is Isabel Martínez, who frequently advises pharma and medical device companies on competition law and digital regulation matters.

The practice group at CMS Albiñana y Suárez de Lezo handles transactional, IP and regulatory matters on behalf of pharmaceutical, healthcare and medical device companies. Leadership of the team is shared between María González Gordon, who also heads up the firm’s IP offering and is well-versed in the drafting of IP agreements; Mariano Bautista, who specialises in corporate law, M&A and restructuring; and public law-focused Ignacio Grangel.

The team at HOYNG ROKH MONEGIER is highly specialised in IP matters in the life sciences sphere, offering particular expertise in patent litigation. Luis Fernández-Novoa leads the practice group and covers the gamut of IP issues, namely patents, trade marks, copyrights and unfair competition matters. Álvaro Velázquez and Laura Cantero are additional key contacts for IP litigation on behalf of pharmaceutical companies.

Marimón Abogados‘s practice routinely provides regulatory, competition, public law and transactional support to stakeholders in the pharma, biotech, medical device and cosmetic spaces. Acting as department co-heads are Barcelona-based Yolanda Martínez, who focuses on advising pharmaceutical companies on competition and regulatory issues affecting market access and pricing, and competition law specialist Diego Crespo, who has deep knowledge of the food and beverage, consumer goods and transport sectors.

Ramón y Cajal Abogados‘s practice group is equipped to handle authorisations for the commercialisation of medications, administrative and jurisdictional proceedings and corporate transactions in the life sciences space. The team is co-led by José Ignacio Vega, who specialises in public procurement and life sciences regulatory matters, and Norman Heckh, who focuses on commercial law, data protection, IP and telecoms mandates.